Global Anaplastic Thyroid Cancer Clinical Trials Review, H2 2018 by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status - ResearchAndMarkets.com

The "Anaplastic
Thyroid Cancer Global Clinical Trials Review, H2, 2018"
clinical trials has been added to ResearchAndMarkets.com's
offering.

"Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2018"
provides an overview of Anaplastic Thyroid Cancer clinical trials
scenario. This report provides top line data relating to the clinical
trials on Anaplastic Thyroid Cancer. Report includes an overview of
trial numbers and their average enrollment in top countries conducted
across the globe.

The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials). These reports are generated using a
proprietary database - Pharma eTrack Clinical trials database. Clinical
trials are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by
  Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
  End point status
• The report reviews top companies involved and enlists all trials
  (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated,
  Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Key Topics Covered:

1. List of Tables
2. List of Figures
3. Report Guidance
4. Clinical Trials Report Coverage
5. Clinical Trials by Region
6. Clinical Trials and Average Enrollment by Country
7. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
8. Top Five Countries Contributing to Clinical Trials in Europe
9. Top Countries Contributing to Clinical Trials in North America
10. Top Countries Contributing to Clinical Trials in Middle East and Africa
11. Top Countries Contributing to Clinical Trials in Central and South
    America
12. Clinical Trials by G7 Countries: Proportion of Anaplastic Thyroid
    Cancer to Oncology Clinical Trials
13. Clinical Trials by Phase in G7 Countries
14. Clinical Trials in G7 Countries by Trial Status
15. Clinical Trials by E7 Countries: Proportion of Anaplastic Thyroid
    Cancer to Oncology Clinical Trials
16. Clinical Trials by Phase in E7 Countries
17. Clinical Trials in E7 Countries by Trial Status
18. Clinical Trials by Phase
19. In Progress Trials by Phase
20. Clinical Trials by Trial Status
21. Clinical Trials by End Point Status
22. Subjects Recruited Over a Period of Time
23. Clinical Trials by Sponsor Type
24. Prominent Sponsors
25. Top Companies Participating in Anaplastic Thyroid Cancer Therapeutics
    Clinical Trials
26. Prominent Drugs
27. Clinical Trial Profile Snapshots
28. Appendix
    

Companies Mentioned

• Eisai Co Ltd
• Novartis AG
• Daiichi Sankyo Co Ltd
• Bayer AG
• Mateon Therapeutics Inc
• F. Hoffmann-La Roche Ltd
• Pfizer Inc
• Merck & Co Inc
• Exelixis Inc
• AstraZeneca Plc

For more information about this clinical trials report visit https://www.researchandmarkets.com/research/4qx76v/global_anaplastic?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190225005707/en/